Market Tracker

06/28 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.2565
Delayed Data
As of 4:01pm ET
 +0.0078 / +3.14%
Today’s Change
0.24
Today|||52-Week Range
0.67
-29.34%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.25
Today’s open0.25
Day’s range0.25 - 0.26
Volume430,125
Average volume (3 months)567,202
Market cap$53.0M
Dividend yield--
Data as of 4:01pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+27.27%
Earnings growth (this year)-12.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
AVIRAviragen Therapeutic...0.000.00%
AVEOAveo Pharmaceuticals...+0.02+2.21%
XOMAXOMA Corp+0.00+0.84%
MTEXMannatech Inc+0.40+2.00%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts